FS/10/005/28147./BHF_/British Heart Foundation/United Kingdom[Grants and Funding] - Search Results

Year	Number of Results
2011	4
2012	5
2013	5
2014	3
2024	0

1

Circulating interleukin-10 and risk of cardiovascular events: a prospective study in the elderly at risk.

Welsh P, Murray HM, Ford I, Trompet S, de Craen AJ, Jukema JW, Stott DJ, McInnes IB, Packard CJ, Westendorp RG, Sattar N; PROSPER Study Group. Welsh P, et al. Arterioscler Thromb Vasc Biol. 2011 Oct;31(10):2338-44. doi: 10.1161/ATVBAHA.111.231795. Epub 2011 Jul 14. Arterioscler Thromb Vasc Biol. 2011. PMID: 21757655 Free article. Clinical Trial.

2

Association of N-terminal pro-brain natriuretic peptide with cognitive function and depression in elderly people with type 2 diabetes.

Feinkohl I, Sattar N, Welsh P, Reynolds RM, Deary IJ, Strachan MW, Price JF; Edinburgh Type 2 Diabetes Study-ET2DS Investigators. Feinkohl I, et al. PLoS One. 2012;7(9):e44569. doi: 10.1371/journal.pone.0044569. Epub 2012 Sep 4. PLoS One. 2012. PMID: 22973461 Free PMC article.

3

The relative and combined ability of high-sensitivity cardiac troponin T and N-terminal pro-B-type natriuretic peptide to predict cardiovascular events and death in patients with type 2 diabetes.

Hillis GS, Welsh P, Chalmers J, Perkovic V, Chow CK, Li Q, Jun M, Neal B, Zoungas S, Poulter N, Mancia G, Williams B, Sattar N, Woodward M. Hillis GS, et al. Diabetes Care. 2014;37(1):295-303. doi: 10.2337/dc13-1165. Epub 2013 Oct 2. Diabetes Care. 2014. PMID: 24089534 Free article.

4

N-terminal pro brain natriuretic peptide but not copeptin improves prediction of heart failure over other routine clinical risk parameters in older men with and without cardiovascular disease: population-based study.

Wannamethee SG, Welsh P, Whincup PH, Lennon L, Papacosta O, Sattar N. Wannamethee SG, et al. Eur J Heart Fail. 2014 Jan;16(1):25-32. doi: 10.1093/eurjhf/hft124. Epub 2013 Dec 3. Eur J Heart Fail. 2014. PMID: 23901058 Free article.

5

Mendelian randomization study of B-type natriuretic peptide and type 2 diabetes: evidence of causal association from population studies.

Pfister R, Sharp S, Luben R, Welsh P, Barroso I, Salomaa V, Meirhaeghe A, Khaw KT, Sattar N, Langenberg C, Wareham NJ. Pfister R, et al. PLoS Med. 2011 Oct;8(10):e1001112. doi: 10.1371/journal.pmed.1001112. Epub 2011 Oct 25. PLoS Med. 2011. PMID: 22039354 Free PMC article.

6

Increasing requests for vitamin D measurement: costly, confusing, and without credibility.

Sattar N, Welsh P, Panarelli M, Forouhi NG. Sattar N, et al. Lancet. 2012 Jan 14;379(9811):95-6. doi: 10.1016/S0140-6736(11)61816-3. Lancet. 2012. PMID: 22243814 No abstract available.

7

N-terminal pro-brain natriuretic Peptide is a more useful predictor of cardiovascular disease risk than C-reactive protein in older men with and without pre-existing cardiovascular disease.

Wannamethee SG, Welsh P, Lowe GD, Gudnason V, Di Angelantonio E, Lennon L, Rumley A, Whincup PH, Sattar N. Wannamethee SG, et al. J Am Coll Cardiol. 2011 Jun 28;58(1):56-64. doi: 10.1016/j.jacc.2011.02.041. J Am Coll Cardiol. 2011. PMID: 21700090 Free article.

8

25-Hydroxyvitamin D is lower in deprived groups, but is not associated with carotid intima media thickness or plaques: results from pSoBid.

Knox S, Welsh P, Bezlyak V, McConnachie A, Boulton E, Deans KA, Ford I, Batty GD, Burns H, Cavanagh J, Millar K, McInnes IB, McLean J, Velupillai Y, Shiels P, Tannahill C, Packard CJ, Michael Wallace A, Sattar N. Knox S, et al. Atherosclerosis. 2012 Aug;223(2):437-41. doi: 10.1016/j.atherosclerosis.2012.05.001. Epub 2012 May 9. Atherosclerosis. 2012. PMID: 22632919 Free article.

9

Prospective study of circulating soluble CD40 ligand concentrations and the incidence of cardiovascular disease in a nested prospective case-control study of older men and women.

Jefferis BJ, Whincup PH, Welsh P, Wannamethee SG, Rumley A, Lawlor DA, Ebrahim S, Lowe GD. Jefferis BJ, et al. J Thromb Haemost. 2011 Aug;9(8):1452-9. doi: 10.1111/j.1538-7836.2011.04415.x. J Thromb Haemost. 2011. PMID: 21696538 Free article.

10

N-terminal pro-B-type natriuretic peptide and the prediction of primary cardiovascular events: results from 15-year follow-up of WOSCOPS.

Welsh P, Doolin O, Willeit P, Packard C, Macfarlane P, Cobbe S, Gudnason V, Di Angelantonio E, Ford I, Sattar N. Welsh P, et al. Eur Heart J. 2013 Feb;34(6):443-50. doi: 10.1093/eurheartj/ehs239. Epub 2012 Aug 31. Eur Heart J. 2013. PMID: 22942340 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

13 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year